Aberrant methylation of the ID4 promoter region is associated with invasiveness, growth, and recurrence of many solid tumors [26,29-34] and with initiation and progression in hematological cancers including leukemia and lymphoma [23,26,29,35]. This evidence concerns the gene ID4 and leukemia.